Pyxis Oncology Inc
PYXS - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$114.67M
Close$
$0.37
77.5% downside
Current Fair Value
77.5% downsideOvervalued by 77.5% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $114.67 Million |
|---|---|
| Enterprise Value | $113.65 Million |
| Earnings per Share | $-1.28 |
| Beta | 1.38 |
| Outstanding Shares | 63,991,609 |
Return
| Return on Equity | -775.59% |
|---|---|
| Return on Assets | -161.55% |
| Return on Invested Capital | -336.04% |
Valuation & Multiples
| P/E Ratio | -1.28 |
|---|---|
| PEG | -3.37 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 10.3 |
| Enterprise Value to EBIT | -1.23 |
| Enterprise Value to Net Income | -2 |
| Total Debt to Enterprise | 0.16 |
| Debt to Equity | 1.56 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 2, 2026
EPS Estimate
$-0.27
Consensus analyst estimateRevenue Estimate
-
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 3.61% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 7.83%▼ 45.55% |
|---|---|
| Total Invested | $11.69M▼ 88.45% |
| Investors Holding | 6▼ 77.00% |